×
Site Menu
Everything
Politics
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Health
Neurocrine to Buy Soleno, Nabbing Drug for Relentless Hunger Disorder
3 months ago
43
The deal, valued astatine $2.9 billion, volition grow Neurocrine’s endocrinology and rare-disease portfolio.
Read Entire Article
Homepage
Technology
Neurocrine to Buy Soleno, Nabbing Drug for Relentless Hunger Disorder
Related
'More than 2,700 deaths' linked to May and June heatwaves
9 hours ago
1
Apple’s ‘Thermonuclear’ Response to the OpenAI Threat
9 hours ago
1
Can a Prettier Data Center Curb the Community Backlash?
16 hours ago
4
Popular
Clusters of Severe Stomach Illness Reported Across the U.S.
6 days ago
17
Platner’s Democratic Support Evaporates After Sexual Assault...
6 days ago
16
What really worries Reform about Posh George?
6 days ago
16
Heat waves are taking a big toll on chickens
6 days ago
15
New Strikes on Ships in Strait of Hormuz Test U.S.-Iran Ceas...
6 days ago
15